Real-World test for stroke drug aims to confirm safety and effectiveness
NCT ID NCT00412867
Summary
This study aimed to confirm the real-world safety and effectiveness of the clot-dissolving drug alteplase for patients having an acute ischemic stroke. It involved 58 patients who received the drug within 3 hours of stroke symptoms starting. Researchers measured how well the drug restored blood flow to the brain and tracked patients' recovery and any serious bleeding risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site 01
Hokkaido, Japan
Conditions
Explore the condition pages connected to this study.